Joshua Jackson, MD, PhD

Resident
Duke University
Durham, NC, US

Disclosure(s): No financial relationships to disclose

Presentation(s):

• Type I Interferon Signaling within Glioblastoma Tumor Cells Promotes T cell Exhaustion and Resistance to Checkpoint Inhibitors

  Sunday, May 5, 2024
  1:41 PM – 1:43 PM CT